Trial Profile
A study evaluating predictors of success, visual outcomes, and complications in patients treated with Ocriplasmin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Ocriplasmin (Primary)
- Indications Diabetic neuropathies; Retinal disorders; Retinal vein occlusion
- Focus Therapeutic Use
- 05 Mar 2018 New trial record